A look back at some of 2021’s key highlights at StaniPharm

Manufacturing of clinical GMP batches of a new vaccine adjuvant, development of innovative cannabis-based medicines …

Cybernano and StaniPharm join forces to develop tomorrow’s health products

The complementary nature of their expertise and technologies will provide complete support for start-ups and SMEs from development through clinical trials.

Vaxinano partners with StaniPharm for development and production of its vaccine delivery system

“Scaling up this kind of vaccine delivery system is a crucial step and requires a strong partner” says Dr. Didier Betbeder, CEO of Vaxinano.